TY - JOUR
KW - Adult
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Diabetes Mellitus, Type 2/complications
KW - Female
KW - Glycated Hemoglobin A/analysis
KW - Humans
KW - Male
KW - Middle Aged
KW - Ontario
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Retrospective Studies
AU - Devon Tilbrook
AU - Jeffrey Jacob
AU - Pierre Parsons
AU - Craig Edwards
AU - Kassandra Loewen
AU - Len Kelly
A1 - 
AD - Physician practising in Sioux Lookout, Ont. devon.tilbrook@gmail.com.; Health Director of Webequie First Nation in Ontario.; Electronic Medical Records Technologist for Sioux Lookout First Nations Health Authority.; Researcher for the Anishinaabe Bimaadiziwin Research Program.; Research intern for the Anishinaabe Bimaadiziwin Research Program.; Research consultant for the Anishinaabe Bimaadiziwin Research Program.
BT - Canadian family physician Medecin de famille canadien
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 7
CY - Canada
IS - 7
JF - Canadian family physician Medecin de famille canadien
LA - eng
M1 - Journal Article
PP - Canada
PY - 2017
SN - 1715-5258; 0008-350X
SP - e350
EP - e354
EP - 
T1 - Opioid use disorder and type 2 diabetes mellitus: Effect of participation in buprenorphine-naloxone substitution programs on glycemic control
T2 - Canadian family physician Medecin de famille canadien
TI - Opioid use disorder and type 2 diabetes mellitus: Effect of participation in buprenorphine-naloxone substitution programs on glycemic control
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 28701461
VL - 63
VO - 1715-5258; 0008-350X
Y1 - 2017
Y2 - Jul
ER -